Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease
Xinxing Wu1, Chong Peng2, Peter T Nelson3
1Institute for Biomedical Informatics, University of Kentucky, Lexington, KY, USA.
Background:
The progression of Alzheimer's disease (AD) varies in different patients at different stages, which makes predicting the time of disease conversions challenging.
Objective:
We established an algorithm by leveraging machine learning techniques to predict the probability of the conversion time to next stage for different subjects during a given period.
Methods:
Firstly, we used Kaplan-Meier (KM) estimation to get the transition curves of different AD stages, and calculated Log-rank statistics to test whether the progression rate between different stages was identical. This quantitatively confirmed the progression rates known in the literature. Then, we developed an approach based on deep learning model, DeepSurv, to predict the probabilities of time-to-conversion. Finally, to help interpret the deep learning model in our approach, we identified important variables contributing the most to the DeepSurv prediction, whose significance were validated with the analysis of variance (ANOVA).
Results:
Our machine learning approach predicted the time to conversion with a high accuracy. For each of the different stages, the concordance index (CI) of our approach was at least 86%, and the integrated Brier score (IBS) was less than 0.1. To facilitate interpretability of the prediction results, our approach identified the top 10 variables for each disease conversion scenario, which were clinicopathologically meaningful, and most of them were also statistically significant.
Conclusion:
Our study has the potential to provide individualized prediction for future time course of AD conversions years before their actual occurrence, thus facilitating personalized prevention and intervention strategies to slow down the progression of AD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

